Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMar 27, 2019Morphine Sulfate 30 mg/30 mLLack of Assurance of SterilityAdvanced Pharma Inc. · D-1033-2019Class IITerminatedMar 27, 2019Phenylephrine HClLack of Assurance of SterilityAdvanced Pharma Inc. · D-1032-2019Class IITerminatedMar 27, 2019Heparin 5Lack of Assurance of SterilityAdvanced Pharma Inc. · D-1031-2019Class IITerminatedMar 27, 2019Heparin 10 Units/10 mL 10 Units in 0.45% Sodium ChlorideLack of Assurance of SterilityAdvanced Pharma Inc. · D-1030-2019Class IITerminatedMar 27, 2019Esmolol HCl Injectable Solution 100 mg/10 mLLack of Assurance of SterilityAdvanced Pharma Inc. · D-1029-2019Class IITerminatedMar 27, 2019Phenylephrine HClLack of Assurance of SterilityAdvanced Pharma Inc. · D-1028-2019Class IITerminatedMar 27, 20192% Lidocaine HCl Injectable SolutionLack of Assurance of SterilityAdvanced Pharma Inc. · D-1027-2019Class IITerminatedMar 27, 20192% Lidocaine HCl Injectable SolutionLack of Assurance of SterilityAdvanced Pharma Inc. · D-1026-2019Class IITerminatedMar 27, 2019Glycopyrrolate 0.6 mg/3 mLLack of Assurance of SterilityAdvanced Pharma Inc. · D-1025-2019Class IITerminatedMar 27, 2019Neostigmine Methylsulfate Injection Solution 5 mg/5mLLack of Assurance of SterilityAdvanced Pharma Inc. · D-1024-2019Class IITerminatedMar 27, 2019Phenylephrine HClLack of Assurance of SterilityAdvanced Pharma Inc. · D-1023-2019Class IITerminatedMar 27, 2019Phenylephrine HClLack of Assurance of SterilityAdvanced Pharma Inc. · D-1022-2019Class IITerminatedMar 27, 2019Glycopyrrolate Injectable Solution 1 mg/5 mLLack of Assurance of SterilityAdvanced Pharma Inc. · D-1021-2019Class IITerminatedMar 27, 2019Phenylephrine HClLack of Assurance of SterilityAdvanced Pharma Inc. · D-1020-2019Class IITerminatedMar 27, 2019Midazolam Benzodiazepine 50 mg/50 mLLack of Assurance of SterilityAdvanced Pharma Inc. · D-1019-2019Class IITerminatedMar 27, 2019fentaNYL 2500 mcg/250 mL Injectable SolutionLack of Assurance of SterilityAdvanced Pharma Inc. · D-1018-2019Class IITerminatedMar 27, 2019fentaNYL 1000 mcg/100 mL Injectable Solution Fentanyl 0.9% Sodium ChlorideLack of Assurance of SterilityAdvanced Pharma Inc. · D-1017-2019Class IITerminatedMar 27, 2019HYDROmorphone HCl 1 mg in 0.9% Sodium ChlorideLack of Assurance of SterilityAdvanced Pharma Inc. · D-1016-2019Class IITerminatedMar 27, 2019Alprazolam TabletsFailed Impurities/Degradation Specifications: Elevated levels of a known impurity detected during 6-month RT stability interval.Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · D-1013-2019Class IITerminatedMar 27, 2019Hydrocortisone and Acetic Acid Otic SolutionSub Potent Drug: OOS results observed for the Hydrocortisone assay during routine stability testing at 12 month controlled room temperature.Akorn Inc · D-1011-2019Class IIITerminatedMar 27, 2019Testosterone Topical SolutionDefective Container: Repetitive complaints received indicating pump not working.Lupin Pharmaceuticals Inc. · D-1010-2019Class IITerminatedMar 27, 2019VolumexLack of Assurance of Sterility: preliminary environmental monitoring report exceeds limits, therefore sterility cannot be assured.Iso-Tex Diagnostics, Inc · D-1008-2019Class IITerminatedMar 27, 2019Docusate SodiumLabeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.Rx Pak Division of McKesson Corporation · D-1007-2019Class IIITerminatedMar 27, 2019Lansoprazole Delayed-Release Orally Disintegrating TabletsSubpotent Drug.Teva Pharmaceuticals USA · D-1006-2019Class ITerminatedMar 20, 2019Levoleucovorin InjectionPresence of Particulate Matter: particulate matter identified as copper saltsMylan Institutional Inc · D-1059-2019Class IITerminatedMar 20, 2019Little Remedies New Baby Essentials Kit. Each kit contains 1 each of the following products: Little Remedies...Incorrect/undeclared excipients: Kit carton bear incorrect labeling for two of the five items contained within the kit.Medtech Products, Inc. · D-1012-2019Class ITerminatedMar 20, 2019Golean DETOX capsulesMarketed Without an Approved NDA/ANDA: FDA analysis found product to contain undeclared sibutramine and phenolphthalein. Sibutramine is an appetite suppressant that was...Golean Detox US · D-1009-2019Class IITerminatedMar 20, 2019Telmisartan and Hyrdochlorothiazide Tablets 80 mg/25 mgFailed Content Uniformity Specifications: The product is out of specification for blend uniformity.Macleods Pharma Usa Inc · D-1005-2019Class IITerminatedMar 20, 2019Telmisartan and Hyrdochlorothiazide TabletsFailed Content Uniformity Specifications: The product is out of specification for blend uniformity.Macleods Pharma Usa Inc · D-1004-2019Class IITerminatedMar 20, 2019Telmisartan and Hyrdochlorothiazide Tablets 40mg/12.5 mgFailed Content Uniformity Specifications: The product is out of specification for blend uniformity.Macleods Pharma Usa Inc · D-1003-2019Class IITerminatedMar 20, 2019Oxygen, Refrigerated Liquid USPCGMP DeviationsRoberts Home Medical LLC · D-1002-2019Class IITerminatedMar 20, 2019Docetaxel Injection USPDefective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.Dr. Reddy's Laboratories, Inc. · D-1001-2019Class IIITerminatedMar 20, 2019Oxybutynin ChlorideFailed Dissolution SpecificationsLannett Company Inc. · D-0996-2019Class IITerminatedMar 20, 2019Gentamicin Sulfate Ophthalmic SolutionFailed Impurities/Degradation Specifications: High Out-of-Specification (OOS) results for Individual and Total Impurities that have been identified at the 18 months...Akorn, Inc. · D-0993-2019Class IIITerminatedMar 20, 2019MirapexFailed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.Boehringer Ingelheim Pharmaceuticals, Inc. · D-0991-2019Class IIITerminatedMar 20, 2019Oxybutynin Chloride Extended-Release Tablets USP 10 mgFailed Dissolution SpecificationsAVKARE Inc. · D-0990-2019Class ITerminatedMar 20, 2019Dr. King's SafeCare Rx Breast Cyst & Discomforts High Potency Homeopathic Formula for Professional Use OnlyMicrobial contaminationKing Bio Inc. · D-0985-2019Class ITerminatedMar 20, 2019Dr. King's SafeCare Rx Aversion to Change High Potency Homeopathic Formula for Professional Use OnlyMicrobial contaminationKing Bio Inc. · D-0984-2019Class ITerminatedMar 20, 2019Dr. King's Natural Medicine Regional Allergies Hawaii U.S. HomeopathicMicrobial contaminationKing Bio Inc. · D-0983-2019Class ITerminatedMar 20, 2019Dr. King's Natural Medicine Leg Cramp & Spasm Relief HomeopathicMicrobial contaminationKing Bio Inc. · D-0982-2019